La Vista, NE – Streck, Inc. will sponsor a free one-hour webinar on liquid biopsy-based cancer research featuring speaker Prof. Dr. med. Stefan Holdenrieder, director of the Institute of Laboratory Medicine, German Heart Center of the Technical University, Munich. The webinar will begin at 9 a.m. EDT on Oct. 10, 2018.
The webinar, “Recent Advances and Challenges in Liquid Biopsy-Based Cancer Research,” will provide an overview of liquid biopsy-based diagnosis and include an overview about nucleic acid-based liquid biopsy approaches in blood and other bodily fluids. The webinar will discuss key challenges for choice of appropriate materials, tubes and pre-analytical sample handling, analytical considerations regarding technologies, quality control, optimization of accuracy and data interpretation strategies. Holdenrieder will delineate the clinical application of liquid biopsy for diagnosis, therapy stratification, therapy and residual disease monitoring in cancer patients and give an outlook on new fields of diagnostic application in cardiovascular diseases and transplantation medicine.
Those participating in the webinar will learn about recent developments in liquid biopsy using different matrices and technologies; get to know diverse nucleic-acid-based diagnostic approaches; identify key challenges in the pre-analytical, analytical and post-analytical process; learn about clinical indications for liquid biopsy application; and discuss the current status of clinical studies on liquid biopsy in cancer disease.
Joel Lechner, M.S., Product Manager-Marketing, will represent Streck. Lechner earned his master’s degree in biochemistry from the University of Nebraska-Lincoln and worked in Streck Research and Development for nearly a decade. His current role is product manager for products including Cell-Free DNA BCT® (Cell-Free DNA BCT is for Research Use Only. Not for use in diagnostic procedures. A CE version of these tubes is also available.) and Cell-Free RNA BCT® (Cell-Free RNA BCT is for Research Use Only. Not for use in diagnostic procedures. A CE version of these tubes is also available.), as well as Cell-Free DNA Urine Preserve.
About Streck, Inc.
Established in 1971, Streck develops and manufactures hematology, immunology and molecular biology laboratory products. Innovative products include kits for antibiotic resistance detection and a hot-start PCR enzyme. For more information, visit www.streck.com.